HMGB1 Inhibits Apoptosis Following MI and Induces Autophagy via mTORC1 Inhibition

Journal of Cellular Physiology

Volumn 232, Issue 5, 2017, Pages 1135-1143

  Foglio, Eleonora ^a   Puddighinu, Giovanni ^a   Germani, Antonia ^b   Russo, Matteo A ^c   Limana, Federica ^c,d  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b LABORATORIO DI PATOLOGIA VASCOLARE   (Italy)

^c VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^d IRCCS SAN RAFFAELE PISANA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOPHAGY RELATED PROTEIN 7; BECLIN 1; HIGH MOBILITY GROUP B1 PROTEIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; MAMMALIAN TARGET OF RAPAMYCIN COMPLEX 1; BIOLOGICAL MARKER; MECHANISTIC TARGET OF RAPAMYCIN COMPLEX 1; MULTIPROTEIN COMPLEX; TARGET OF RAPAMYCIN KINASE;

ACUTE HEART INFARCTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; AUTOPHAGY; CARDIAC MUSCLE CELL; CELL ISOLATION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INHIBITION; FEMALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION; ANIMAL; ANTAGONISTS AND INHIBITORS; C57BL MOUSE; CELL SEPARATION; CELL SURVIVAL; DRUG EFFECTS; HEART FUNCTION TEST; HEART INFARCTION; HEART LEFT VENTRICLE FUNCTION; HEART VENTRICLE REMODELING; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; SIGNAL TRANSDUCTION;

AMP-ACTIVATED PROTEIN KINASES; ANIMALS; APOPTOSIS; AUTOPHAGY; BIOMARKERS; CELL SEPARATION; CELL SURVIVAL; ENZYME ACTIVATION; FEMALE; HEART FUNCTION TESTS; HMGB1 PROTEIN; MICE, INBRED C57BL; MULTIPROTEIN COMPLEXES; MYOCARDIAL INFARCTION; MYOCYTES, CARDIAC; SIGNAL TRANSDUCTION; TOR SERINE-THREONINE KINASES; VENTRICULAR FUNCTION, LEFT; VENTRICULAR REMODELING;

EID: 84988592843     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.25576     Document Type: Article

References (42)

1. Abbate A, Bussani R, Biondi-Zoccai GG, Santini D, Petrolini A, De Giorgio F, Vasaturo F, Scarpa S, Severino A, Liuzzo G, Leone AM, Baldi F, Sinagra G, Silvestri F, Vetrovec GW, Crea F, Biasucci LM, Baldi A. 2005. Infarct-related artery occlusion, tissue markers of ischaemia, and increased apoptosis in the peri-infarct viable myocardium. Eur Heart J 26:2039–2045.
2. Andrassy M, Volz HC, Igwe JC, Funke B, Eichberger SN, Kaya Z, Buss S, Autschbach F, Pleger ST, Lukic IK, Bea F, Hardt SE, Humpert PM, Bianchi ME, Mairbaurl H, Nawroth PP, Remppis A, Katus HA, Bierhaus A. 2008. High-mobility group box-1 in ischemia-reperfusion injury of the heart. Circulation 117:3216–3226.
3. Biscetti F, Ghirlanda G, Flex A. 2011. Therapeutic potential of high mobility group box-1 in ischemic injury and tissue regeneration. Curr Vasc Pharmacol 9:677–681.
4. Buss SJ, Muenz S, Riffel JH, Malekar P, Hagenmueller M, Weiss CS, Bea F, Bekeredjian R, Schinke-Braun M, Izumo S, Katus HA, Hardt SE. 2009. Beneficial effects of Mammalian target of rapamycin inhibition on left ventricular remodeling after myocardial infarction. J Am Coll Cardiol 54:2435–2446.
5. Buss SJ, Riffel JH, Katus HA, Hardt SE. 2010. Augmentation of autophagy by mTOR-inhibition in myocardial infarction: When size matters. Autophagy 6:304–306.
6. De Angelis A, Piegari E, Cappetta D, Marino L, Filippelli A, Berrino L, Ferreira-Martins J, Zheng H, Hosoda T, Rota M, Urbanek K, Kajstura J, Leri A, Rossi F, Anversa P. 2010. Anthracycline cardiomyopathy is mediated by depletion of the cardiac stem cell pool and is rescued by restoration of progenitor cell function. Circulation 121:276–292.
7. Germani A, Limana F, Capogrossi MC. 2007. Pivotal advances: High-mobility group box 1 protein-a cytokine with a role in cardiac repair. J Leukoc Biol 81:41–45.
8. Hou X, Hu Z, Xu H, Xu J, Zhang S, Zhong Y, He X, Wang N. 2014. Advanced glycation endproducts trigger autophagy in cadiomyocyte via RAGE/PI3K/AKT/mTOR pathway. Cardiovasc Diabetol 13:78–2840–13–78.
9. Huang L, Dai K, Chen M, Zhou W, Wang X, Chen J, Zhou W. 2016. The AMPK agonist PT1 and mTOR inhibitor 3HOI-BA-01 protect cardiomyocytes after ischemia through induction of autophagy. J Cardiovasc Pharmacol Ther 21:70–81.
10. Huebener P, Gwak GY, Pradere JP, Quinzii CM, Friedman R, Lin CS, Trent CM, Mederacke I, Zhao E, Dapito DH, Lin Y, Goldberg IJ, Czaja MJ, Schwabe RF. 2014. High-mobility group box 1 is dispensable for autophagy, mitochondrial quality control, and organ function in vivo. Cell Metab 19:539–547.
11. Kabeya Y, Mizushima N, Ueno T, Yamamoto A, Kirisako T, Noda T, Kominami E, Ohsumi Y, Yoshimori T. 2000. LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing. EMBO J 19:5720–5728.
12. Kanamori H, Takemura G, Goto K, Maruyama R, Tsujimoto A, Ogino A, Takeyama T, Kawaguchi T, Watanabe T, Fujiwara T, Fujiwara H, Seishima M, Minatoguchi S. 2011. The role of autophagy emerging in postinfarction cardiac remodelling. Cardiovasc Res 91:330–339.
13. Kang R, Tang D, Schapiro NE, Livesey KM, Farkas A, Loughran P, Bierhaus A, Lotze MT, Zeh HJ. 2010. The receptor for advanced glycation end products (RAGE) sustains autophagy and limits apoptosis, promoting pancreatic tumor cell survival. Cell Death Differ 17:666–676.
14. Kitahara T, Takeishi Y, Harada M, Niizeki T, Suzuki S, Sasaki T, Ishino M, Bilim O, Nakajima O, Kubota I. 2008. High-mobility group box 1 restores cardiac function after myocardial infarction in transgenic mice. Cardiovasc Res 80:40–46.
15. Kohno T, Anzai T, Naito K, Miyasho T, Okamoto M, Yokota H, Yamada S, Maekawa Y, Takahashi T, Yoshikawa T, Ishizaka A, Ogawa S. 2009. Role of high-mobility group box 1 protein in post-infarction healing process and left ventricular remodelling. Cardiovasc Res 81:565–573.
16. Komatsu M, Ichimura Y. 2010. Physiological significance of selective degradation of p62 by autophagy. FEBS Lett 584:1374–1378.
17. Levine B, Kroemer G. 2008. Autophagy in the pathogenesis of disease. Cell 132:27–42.
18. Limana F, Urbanek K, Chimenti S, Quaini F, Leri A, Kajstura J, Nadal-Ginard B, Izumo S, Anversa P. 2002. Bcl-2 overexpression promotes myocyte proliferation. Proc Natl Acad Sci USA 99:6257–6262.
19. Limana F, Germani A, Zacheo A, Kajstura J, Di Carlo A, Borsellino G, Leoni O, Palumbo R, Battistini L, Rastaldo R, Muller S, Pompilio G, Anversa P, Bianchi ME, Capogrossi MC. 2005. Exogenous high-mobility group box 1 protein induces myocardial regeneration after infarction via enhanced cardiac C-kit+ cell proliferation and differentiation. Circ Res 97:e73–e83.
20. Limana F, Zacheo A, Mocini D, Mangoni A, Borsellino G, Diamantini A, De Mori R, Battistini L, Vigna E, Santini M, Loiaconi V, Pompilio G, Germani A, Capogrossi MC. 2007. Identification of myocardial and vascular precursor cells in human and mouse epicardium. Circ Res 101:1255–1265.
21. Limana F, Esposito G, D'Arcangelo D, Di Carlo A, Romani S, Melillo G, Mangoni A, Bertolami C, Pompilio G, Germani A, Capogrossi MC. 2011. HMGB1 attenuates cardiac remodelling in the failing heart via enhanced cardiac regeneration and miR-206-mediated inhibition of TIMP-3. PLoS ONE 6:e19845.
22. Limana F, Esposito G, Fasanaro P, Foglio E, Arcelli D, Voellenkle C, Di Carlo A, Avitabile D, Martelli F, Russo MA, Pompilio G, Germani A, Capogrossi C. 2013. Transcriptional profiling of HMGB1-induced myocardial repair identifies a key role for Notch signaling. Mol Ther 21:1841–1851.
23. Maejima Y, Isobe M, Sadoshima J. 2015. Regulation of autophagy by beclin 1 in the heart. J Mol Cell Cardiol 95:19–25.
24. Matsui Y, Takagi H, Qu X, Abdellatif M, Sakoda H, Asano T, Levine B, Sadoshima J. 2007. Distinct roles of autophagy in the heart during ischemia and reperfusion: Roles of AMP-activated protein kinase and Beclin 1 in mediating autophagy. Circ Res 100:914–922.
25. Nakai A, Yamaguchi O, Takeda T, Higuchi Y, Hikoso S, Taniike M, Omiya S, Mizote I, Matsumura Y, Asahi M, Nishida K, Hori M, Mizushima N, Otsu K. 2007. The role of autophagy in cardiomyocytes in the basal state and in response to hemodynamic stress. Nat Med 13:619–624.
26. Nakamura Y, Suzuki S, Shimizu T, Miyata M, Shishido T, Ikeda K, Saitoh S, Kubota I, Takeishi Y. 2015. High mobility group box 1 promotes angiogenesis from bone marrow-derived endothelial progenitor cells after myocardial infarction. J Atheroscler Thromb 22:570–581.
27. Narumi T, Shishido T, Otaki Y, Kadowaki S, Honda Y, Funayama A, Honda S, Hasegawa H, Kinoshita D, Yokoyama M, Nishiyama S, Takahashi H, Arimoto T, Miyamoto T, Watanabe T, Tanaka A, Woo CH, Abe J, Takeishi Y, Kubota I. 2015. High-mobility group box 1-mediated heat shock protein beta 1 expression attenuates mitochondrial dysfunction and apoptosis. J Mol Cell Cardiol 82:1–12.
28. Nishida K, Otsu K. 2015. Autophagy during cardiac remodeling. J Mol Cell Cardiol 95:11–18.
29. Pan H, Cai N, Li M, Liu GH, Belmonte Izpisua. 2013. Autophagic control of cell “stemness.” EMBO Mol Med 5:327–331.
30. Pattison JS, Osinska H, Robbins J. 2011. Atg7 induces basal autophagy and rescues autophagic deficiency in CryABR120G cardiomyocytes. Circ Res 109:151–160.
31. Riquelme JA, Chavez MN, Mondaca-Ruff D, Bustamante M, Vicencio JM, Quest AF, Lavandero S. 2016. Therapeutic targeting of autophagy in myocardial infarction and heart failure. Expert Rev Cardiovasc Ther 14:1007–1019.
32. Schiattarella GG, Hill JA. 2015. Therapeutic targeting of autophagy in cardiovascular disease. J Mol Cell Cardiol 95:86–93.
33. Sciarretta S, Zhai P, Shao D, Maejima Y, Robbins J, Volpe M, Condorelli G, Sadoshima J. 2012. Rheb is a critical regulator of autophagy during myocardial ischemia: Pathophysiological implications in obesity and metabolic syndrome. Circulation 125:1134–1146.
34. Sciarretta S, Yee D, Shenoy V, Nagarajan N, Sadoshima J. 2014. The importance of autophagy in cardioprotection. High Blood Press Cardiovasc Prev 21:21–28.
35. Takagi H, Matsui Y, Hirotani S, Sakoda H, Asano T, Sadoshima J. 2007. AMPK mediates autophagy during myocardial ischemia in vivo. Autophagy 3:405–407.
36. Takahashi K, Fukushima S, Yamahara K, Yashiro K, Shintani Y, Coppen SR, Salem HK, Brouilette SW, Yacoub MH, Suzuki K. 2008. Modulated inflammation by injection of high-mobility group box 1 recovers post-infarction chronically failing heart. Circulation 118:S106–S114.
37. Taneike M, Yamaguchi O, Nakai A, Hikoso S, Takeda T, Mizote I, Oka T, Tamai T, Oyabu J, Murakawa T, Nishida K, Shimizu T, Hori M, Komuro I, Shirasawa Takuji, Otsu N. 2010. Inhibition of autophagy in the heart induces age-related cardiomyopathy. Autophagy 6:600–606.
38. Tang D, Kang R, Livesey KM, Zeh HJ. 2011. 3rd, lotze MT. High mobility group (HMGB1) activates an autophagic response to oxidative stress. Antioxid Redox Signal 15:2185–2195.
39. Wu X, He L, Chen F, He X, Cai Y, Zhang G, Yi Q, He M, Luo J. 2014. Impaired autophagy contributes to adverse cardiac remodeling in acute myocardial infarction. PLoS ONE 9:e112891.
40. Xu W, Jiang H, Hu X, Fu W. 2014. Effects of high-mobility group box 1 on the expression of Beclin-1 and LC3 proteins following hypoxia and reoxygenation injury in rat cardiomyocytes. Int J Clin Exp Med 7:5353–5357.
41. Yan L, Vatner DE, Kim SJ, Ge H, Masurekar M, Massover WH, Yang G, Matsui Y, Sadoshima J, Vatner SF. 2005. Autophagy in chronically ischemic myocardium. Proc Natl Acad Sci USA 102:13807–13812.
42. Yang L, Yu Y, Kang R, Yang M, Xie M, Wang Z, Tang D, Zhao M, Liu L, Zhang H, Cao L. 2012. Up-regulated autophagy by endogenous high mobility group box-1 promotes chemoresistance in leukemia cells. Leuk Lymphoma 53:315–322.